Ultrafiltration (UF) for Pharmaceutical Manufacturing: Transforming the Industry
Ultrafiltration (UF) is a pressure-driven membrane filtration process that separates suspended solids and solutes of high molecular weight from water and low molecular weight solutes. UF membranes have pore sizes in the range of 0.001 to 0.1 microns, which allows them to retain most bacteria, viruses, and other macromolecules, while allowing water and small molecules to pass through.
UF is a versatile technology that can be used for a variety of purposes in pharmaceutical manufacturing, including:
Concentration:Â UF can be used to concentrate proteins, antibodies, and other biomolecules from fermentation broths and other dilute solutions. This can help to reduce the volume of material that needs to be processed downstream, and can also improve the purity of the product.
According to a report by MarketsandMarkets, the global ultrafiltration market is expected to grow from $12.6 billion in 2022 to $18.4 billion by 2027, at a CAGR of 7.5%. The pharmaceutical segment is one of the major drivers of this growth.
Purification:Â UF can be used to remove impurities from pharmaceutical products, such as proteins, antibodies, and vaccines. This can help to improve the safety and efficacy of the products.
Sterilization:Â UF can be used to sterilize pharmaceutical products without the use of heat or chemicals. This is a particularly important process for products that are sensitive to heat or chemicals, such as vaccines and biologics.
A study published found that UF can be used to sterilize vaccines without affecting their potency or safety.
In addition to these specific applications, UF can also be used in pharmaceutical manufacturing to improve overall productivity and efficiency. For example, UF can be used to recycle water and other solvents, which can help to reduce costs and waste. UF can also be used to automate processes, which can help to improve productivity and reduce the risk of human error.
Grab the PDFÂ Report Here: